Article
Applications of high-throughput DNA sequencing to benign hematology
11 Sept 2013
Abstract excerpt
The development of novel technologies for high-throughput DNA sequencing is having a major impact on our ability to measure and define normal and pathologic variation in humans. This review discusses advances in DNA sequencing that have been applied to benign hematologic disorders, including those affecting the red blood cell, the neutrophil, and other white blood cell lineages. Relevant examples of how these...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
